Population Pharmacokinetics of Amikacin in Korean Neonates
نویسندگان
چکیده
منابع مشابه
Clinical Pharmacokinetics of Amikacin in Neonates
Amikacin is a bactericidal aminoglycoside. Aminoglycosides inhibit bacterial protein synthesis. The antibacterial spectrum of amikacin is the broadest of aminoglycosides. Because of its resistance to many of the aminoglycosides-inactivating enzymes, it has a special role in hospitals where gentamicin- and tobramycin-resistant microorganisms are prevalent. Amikacin is active against the majority...
متن کاملclinical pharmacokinetics of amikacin in neonates
amikacin is a bactericidal aminoglycoside. aminoglycosides inhibit bacterial protein synthesis. the antibacterial spectrum of amikacin is the broadest of aminoglycosides. because of its resistance to many of the aminoglycosides-inactivating enzymes, it has a special role in hospitals where gentamicin- and tobramycin-resistant microorganisms are prevalent. amikacin is active against the majority...
متن کاملCerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.
To describe and investigate the covariate effects of cerebrospinal fluid (CSF) amikacin pharmacokinetics in neonates, CSF samples were prospectively collected from neonates in whom amikacin had been initiated before a diagnostic lumbar puncture was performed. CSF analysis (amikacin concentration, white blood count [WBC], glucose content, and protein concentration) and amikacin therapeutic drug ...
متن کاملTobramycin population pharmacokinetics in neonates
Objective: To establish a tobramycin dosing schedule for neonates of various gestational ages. Methods: This was a retrospective study with prospective validation. A retrospective study in 470 neonates, with suspected septicemia in the first week of life, was performed. All patients received tobramycin according to the following scheme: neonates with a gestational age of less than 28 weeks rece...
متن کاملPopulation pharmacokinetics of amikacin in critically ill patients.
The pharmacokinetic parameters of amikacin were determined in a population of 20 adults and 36 pediatric patients admitted into an intensive care unit. Amikacin was administered by repeated intravenous infusion over 0.5 h (600 to 1,350 mg for adults; 70 to 1,500 mg for children). The number of administrations ranged from 2 to 17, and the number of samples collected from each patient ranged from...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Korean Society for Clinical Pharmacology and Therapeutics
سال: 2000
ISSN: 1225-5467
DOI: 10.12793/jkscpt.2000.8.2.232